Transgene Revenue

Transgene had revenue of 3.36M EUR in the half year ending June 30, 2024, a decrease of -44.85%. This brings the company's revenue in the last twelve months to 6.49M, down -28.00% year-over-year. In the year 2023, Transgene had annual revenue of 7.90M, down -23.63%.

Revenue (ttm)

6.49M EUR

Revenue Growth

-28.00%

P/S Ratio

n/a

Revenue / Employee

46.06K EUR

Employees

141

Market Cap

76.49M GBP

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.90M	-2.44M	-23.63%
Dec 31, 2022	10.34M	-6.90M	-40.00%
Dec 31, 2021	17.24M	7.67M	80.08%
Dec 31, 2020	9.57M	-3.72M	-28.00%
Dec 31, 2019	13.30M	6.21M	87.69%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	38.20B
GSK plc	31.31B
Haleon	11.24B
Smith & Nephew	4.46B
Hikma Pharmaceuticals	2.39B
ConvaTec Group	1.74B
HUTCHMED (China)	483.31M
Oxford Nanopore Technologies	167.75M

Revenue Rankings